COMBINED OPERATIONS IN PATIENTS WITH RESECTABLE GASTRIC CANCER
https://doi.org/10.29235/1814-6023-2018-15-2-207-214
Abstract
The analysis of the long-term results of treatment of 1065 radically operated gastric cancer patients was carried out. 103 of them underwent combined operations. A statistically significant effect of the nature of the operation performed on the number of postoperative complications (4.9 % after combined operations, 1.1–3.4 % after standard operations) and the incidence of disease progression (39.8 % after combined operations, 17.8–30.1 % after standard operations). Prevalence in the structure of the progression of peritoneal dissemination was noted, the 4-year cumulative incidence of which after combined operations was 41.1 ± 0.3 % and after standard operations – from 13.26 ± 0.02 to 27.27 ± 0.07 %. The latter testifies to a relative radical surgical treatment when a tumor leaves the gastric wall, which requires the use of adjuvant treatment aimed at preventing the progression of gastric cancer, primarily with disseminated peritoneal lesions.
About the Authors
M. Yu. Reutovich
N. N. Alexandrov National Cancer Centre.
Russian Federation
Russian Federation
Mikhail Yu. Reutovich – Ph. D. (Med.), Assistant Professor.
223040, Lesnoy, Minsk region.
O. G. Sukonko
N. N. Alexandrov National Cancer Centre.
Russian Federation
Russian Federation
Oleg G. Sukonko – D. Sc. (Med.), Professor, Director.
223040, Lesnoy, Minsk region.
A. I. Shmak
N. N. Alexandrov National Cancer Centre.
Russian Federation
Russian Federation
Andrei I. Shmak – D. Sc. (Med.), Head of the Laboratory.
223040, Lesnoy, Minsk region.
V. V. Krasko
United Institute of Informatics Problems of the National Academy of Sciences of Belarus.
Russian Federation
Russian Federation
Volha V. Krasko – Ph. D. (Tech.), Assistant Professor, Leading researcher.
6, Surganov Str., 220012, Minsk.
References
1. Yonemura Y., Kawamura T., Nojima N., Bandou E., Keizou T., Fujita H., Michiwa Y., Fujimura T., Fushida S., Ajisaka H., Miwa K. Postoperative results of left upper abdominal evisceration for advanced gastric cancer. Hepatogastroenterology, 2000, vol. 47, no. 32, pp. 571-574.
2. Isozaki H., Tanaki N., Fujii K., Tanigawa N., Okajima K. Improvement of the prognosis of gastric cancer with extensive serosal invasion using left upper abdominal evisceration. Hepatogastroenterology, 2001, vol. 48, no. 40, pp. 1179-1182.
3. Butenko A. V. Combined and advanced operations for gastric cancer. Dr. med sci. diss. Moscow, 1999. 271 p. (in Russian).
4. Saito H., Tsujitani S., Maeda Y., Fukuda K., Yamaguchi K., Ikeguchi M., Maeta M., Kaibara N. Combined resection of invaded organs in patients with T4 gastric carcinoma. Gastric Cancer, 2001, vol. 4, no. 4, pp. 206-211. https://doi.org/10.1007/s101200100023
5. Kitamura K., Tani N., Koike H., Nishida S., Ichikawa D., Taniguchi H., Hagiwara A., Yamagishi H. Combined resection of the involved organs in T4 gastric cancer. Hepatogasroenterology, 2000, vol. 47, no. 36, pp. 1769-1772.
6. Punt C. J., Buyse M., Köhne C. H., Hohenberger P., Labianca R., Schmoll H. J., Pahlman L., Sobrero A., Douillard J. Y. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. Journal of the National Cancer Institute, 2007, vol. 99, no. 13, pp. 998-1003. https://doi.org/10.1093/jnci/djm024
7. Kalbfleisch J. D., Prentice R. L. The Statistical Analysis of Failure Time Data. New York, John Wiley and Sons, 1980. 321 p.
8. Gray R. J. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics, 1988, vol. 16, no. 3, pp. 1141-1154. https://doi.org/10.1214/aos/1176350951
9. R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. The R Project for Statistical Computing. Availble at: http://www.R-project.org (accessed: 01.11.2014).
10. Gray B. (2014). cmprsk: Subdistribution Analysis of Competing Risks. R package version 2.2-7. The R Project for Statistical Computing. Availble at: http://CRAN.R-project.org/package=cmprsk (accessed: 18.08.2017).
11. Yan-Quiroz E. F., Diaz-Plasencia J. A., Burgos-Chávez O. A., Rojas-Vergara A. M., Santillán-Medina J., Vilela-Guillén E. S., Balmaceda-Fraselle T. Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma. Review of Gastroenterology in Peru, 2003, vol. 23, no. 3, pp. 184-191.
12. Shchepotin I. B., Chrony V. A., Nauta R. J., Shabahang M., Buras R. R., Evans S. R. Extended surgical resection in T4 gastric cancer. American Journal of Surgery, 1998, vol. 175, no. 2, pp. 123-126. https://doi.org/10.1016/S0002-9610(97)00268-7
13. Bartlett E. K., Roses R. E., Kelz R. R., Drebin J. A., Fraker D. L., Karakousis G. C. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database. Surgery, 2014, vol. 156, no. 2, pp. 298-304. https://doi.org/10.1016/j.surg.2014.03.022
14. Carboni F., Lepiane P., Santoro R., Lorusso R., Mancini P., Sperduti I., Carlini M., Santoro E. Extended multiorgan resection in T4 gastric carcinoma: 25-year experience. Journal of Surgical Oncology, 2005, vol. 90, no. 2, pp. 95-100. https://doi.org/10.1002/jso.20244
15. Wang W., Li Y. F., Sun X. W., Chen Y. B., Li W., Xu D. Z., Guan X. X., Huang C. Y., Zhang Y. Q., Zhou Z. W. Prognosis of 980 patients with gastric cancer after surgical resection. Chinese Journal of Cancer, 2010, vol. 29, no. 11, pp. 923-930.
16. Gholami S., Janson L., Worhunsky D. J., Tran T. B., Squires M. H., Jin L. X., Spolverato G., Votanopoulos K. I., Schmidt C., Weber S. M., Bloomston M., Cho C. S., Levine E. A., Fields R. C., Pawlik T. M., Maithel S. K., Efron B., Norton J. A., Poultsides G. A. Number of lymph nodes removed and survival after gastric cancer resection: an analysis from the us gastric cancer collaborative. Journal of the American College of Surgeons, 2015, vol. 221, no. 2, pp. 291-299. DOI: 10.1016/j.jamcollsurg.2015.04.024
17. Lowenfeld L., Datta J., Lewis R. S. Jr., McMillan M. T., Mamtani R., Damjanov N., Chandrasekhara V., Karakousis G. C., Drebin J. A., Fraker D. L., Roses R. E. Multimodality treatment of T4 gastric cancer in theunited states: utilization trends and impact on survival. Annals of Surgical Oncology, 2015, vol. 22, suppl. 3, pp. 863-872. DOI: 10.1245/s10434-015-4677-y
18. De Roover A., Detroz B., Detry O., Coimbra C., Polus M., Belaiche J., Meurisse M., Honoré P. Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience. Acta Chirurgica Belgica, 2006, vol. 106, no. 3, pp. 297-301.
19. Kang L. Y., Mok K. T., Liu S. I., Tsai C. C., Wang B. W., Chen I. S., Chen Y. C., Chang B. M., Chou N. H. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion. Journal of the Chinese Medical Association, 2013, vol. 76, no. 8, pp. 425-431. DOI: 10.1016/j.jcma.2013.04.004
20. Sano T., Sasako M. For the Gastric Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG). Randomized controlled trial to evaluate para-aortic lymphadenectomy for gastric cancer (JCOG 9501). 4th International Gastric Cancer Congress, New York, USA, April 30-May 2, 2001. New York, 2001, pp. 645-663.
21. Kobayashi A., Nakagohri T., Konishi M., Inoue K., Takahashi S., Itou M., Sugitou M., Ono M., Saito N., Kinoshita T. Aggressive surgical treatment for T4 gastric cancer. Journal of Gastrointestinal Surgery, 2004, vol. 8, no. 4, pp. 464-470. https://doi.org/10.1016/j.gassur.2003.12.018
22. Simonov N. N., Chartorizhskii V. A., Evtyukhin A. I., Mel’nikov O. R. Rational provision of combined operations for locally advanced gastric cancer. Vestnik khirurgii im. Grekova [The Herald of Surgery named after Grekov], 1997, vol. 156, no. 3, pp. 22-25 (in Russian).
Review
For citations:
Reutovich M.Yu., Sukonko O.G., Shmak A.I., Krasko V.V. COMBINED OPERATIONS IN PATIENTS WITH RESECTABLE GASTRIC CANCER. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2018;15(2):207-214. (In Russ.) https://doi.org/10.29235/1814-6023-2018-15-2-207-214
Views: 734
Email this article 